Subhashini Ayloo1, Michele Molinari2. 1. Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada. 2. Department of Surgery, Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: Michele.molinari@cdha.nshealth.ca.
Abstract
INTRODUCTION: Pancreatic manifestations in Von Hippel-Lindau (VHL) disease can present as a multitude of forms, and their management can be challenging. PRESENTATION OF THE CASE: A 66-year-old woman presented with increasing abdominal girth without other associated symptoms of nausea, vomiting, abdominal pain, weight-loss, and jaundice. Her medical and surgical histories were significant for type II diabetes, cerebral tumor resection, bilateral nephrectomies, and laser photocoagulation of retinal hemangiomas. Computed tomography (CT) of the abdomen showed a massive multi-cystic lesion in the pancreas and the patient was referred to our hepatopancreatic biliary center. DISCUSSION: The findings on the subsequent cross-sectional MRI imaging signified pancreatic manifestations in VHL disease. CONCLUSION: The management of VHL disease-associated benign pancreatic cystic lesions involves interval monitoring with cross-sectional imaging for malignant changes/development.
INTRODUCTION:Pancreatic manifestations in Von Hippel-Lindau (VHL) disease can present as a multitude of forms, and their management can be challenging. PRESENTATION OF THE CASE: A 66-year-old woman presented with increasing abdominal girth without other associated symptoms of nausea, vomiting, abdominal pain, weight-loss, and jaundice. Her medical and surgical histories were significant for type II diabetes, cerebral tumor resection, bilateral nephrectomies, and laser photocoagulation of retinal hemangiomas. Computed tomography (CT) of the abdomen showed a massive multi-cystic lesion in the pancreas and the patient was referred to our hepatopancreatic biliary center. DISCUSSION: The findings on the subsequent cross-sectional MRI imaging signified pancreatic manifestations in VHL disease. CONCLUSION: The management of VHL disease-associated benign pancreatic cystic lesions involves interval monitoring with cross-sectional imaging for malignant changes/development.
Authors: Simon Turcotte; Baris Turkbey; Stephanie Barak; Steven K Libutti; H Richard Alexander; W Marston Linehan; Marybeth S Hughes; Naris Nilubol; Krisana Gesuwan; Corina Millo; Martha Quezado; Peter L Choyke; Electron Kebebew; Giao Q Phan Journal: Surgery Date: 2012-10-27 Impact factor: 3.982
Authors: Michael Charlesworth; Caroline S Verbeke; Gavin A Falk; Matthew Walsh; Andrew M Smith; Gareth Morris-Stiff Journal: J Gastrointest Surg Date: 2012-02-28 Impact factor: 3.452
Authors: Keith A Delman; Suzanne E Shapiro; Eric W Jonasch; Jeffrey E Lee; Steven A Curley; Douglas B Evans; Nancy D Perrier Journal: World J Surg Date: 2006-05 Impact factor: 3.352
Authors: Joseph A Blansfield; Lynda Choyke; Shane Y Morita; Peter L Choyke; James F Pingpank; H Richard Alexander; Geoffrey Seidel; Yvonne Shutack; Nargiza Yuldasheva; Michelle Eugeni; David L Bartlett; Gladys M Glenn; Lindsay Middelton; W Marston Linehan; Steven K Libutti Journal: Surgery Date: 2007-12 Impact factor: 3.982
Authors: Jan M Langrehr; Marcus Bahra; Glen Kristiansen; Hartmut P H Neumann; Luitgard M Neumann; Ursula Plöckinger; Enrique Lopez-Hänninen Journal: J Pediatr Surg Date: 2007-07 Impact factor: 2.545